Similarly, in other types of cancers, Tanshinone I induces autophagy by inhibiting the PI3K/AKT/mTOR pathway, thereby mitigating the malignant biological characteristics of ovarian cancer [50]. Here, MTOR is linked to ovarian carcinoma.